In an interaction with India Pharma Outlook, Vineet Dwivedi, Global Head, Alcon Global Services, discusses how employee engagement in the pharmaceutical industry has evolved to focus on well-being,...
Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals
Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals in a recent interaction with India Pharma Outlook, shared his views on how CFOs in...
Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited
In an interaction with India Pharma Outlook, Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited discusses about the role of organic synthesis...
Vivek Soares, Country Lead, India and South Asia, Organon
In an interaction with India Pharma Outlook, Vivek Soares, Country Lead, India and South Asia, Organon, discusses the progress and gaps in women’s...
Janifha Evangeline, Assistant Editor, India Pharma Outlook
India's status as the "pharmacy of the world" is based on its ability to create drug details and nonexclusive medications. Be that as it may, this...
Rejith P R, Correspondent, India Pharma Outlook
Alembic Pharmaceuticals has received final approval from the US FDA for its generic...
Rejith P R, Correspondent, India Pharma Outlook
Lindy Biosciences, a protein therapeutic formulations firm, has announced a partnership with...
Janifha Evangeline, Assistant Editor, India Pharma Outlook
Owing to the direct impact of its products on public health & safety, the pharma sector...
Computer aided drug design (CADD) has played a pivotal role in...
A milestone has been achieved by Fortis Hospital, Bengaluru...
India has successfully performed the first human clinical...
.jpg "Usage of Conversational AI in the Health Insurance Sector")
At the Conversational AI and Customer Experience summit last...
.jpg "Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management?")
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
.jpg "Why Adapting Flexibility in IP Rights will Drive Generics Market")
.jpg "Meeting the Challenges of High-Potency API (HPAPI) Production")
